Form 4: Generation Bio Co. Executive Sells Shares Under 10b5-1 Plan

Antoinette Paone, Chief Operating Officer of Generation Bio Co., sold 6,719 shares of common stock at $2.74 per share on July 1, 2024, under a pre-arranged trading plan.

Summary

• On July 1, 2024, Antoinette Paone, the Chief Operating Officer of Generation Bio Co., sold 6,719 shares of the company's common stock.
• The sale was executed at a price of $2.74 per share.
• This transaction was conducted under a Rule 10b5-1 trading plan that Ms. Paone adopted on April 24, 2023.
• Following the transaction, Ms. Paone beneficially owns 13,807 shares of Generation Bio Co.
• This total includes 6,710 shares acquired through the company's employee stock purchase plan since April 15, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock sale by an executive under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Sales under 10b5-1 plans are common and allow insiders to sell shares without being accused of trading on non-public information.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates